Previous Article | Next Article 
J Virol, January 1998, p. 641-650, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Effects of Defined Mutations in the 5'
Nontranslated Region of Rubella Virus Genomic RNA on Virus Viability
and Macromolecule Synthesis
Konstantin V.
Pugachev and
Teryl K.
Frey*
Department of Biology, Georgia State
University, Atlanta, Georgia 30303
Received 18 July 1997/Accepted 2 October 1997
 |
ABSTRACT |
The 5' end of the genomic RNA of rubella virus (RUB) contains a
14-nucleotide (nt) single-stranded leader (ss-leader) followed by a
stem-and-loop structure [5'(+)SL] (nt 15 to 65), the complement of
which at the 3' end of the minus-strand RNA [3'(
)SL] has been proposed to function as a promoter for synthesis of genomic plus strands. A second intriguing feature of the 5' end of the RUB genomic
RNA is the presence of a short (17 codons) open reading frame (ORF)
located between nt 3 and 54; the ORF encoding the viral nonstructural
proteins (NSPs) initiates at nt 41 in an alternate translational frame.
To address the functional significance of these features, we compared
the 5'-terminal sequences of six different strains of RUB, with the
result that the short ORF is preserved (although the coding sequence is
not conserved) as is the stem part of both the 5'(+)SL and 3'(
)SL,
while the upper loop part of both structures varies. Next, using
Robo302, an infectious cDNA clone of RUB, we introduced 31 different
mutations into the 5'-terminal noncoding region, and their effects on
virus replication and macromolecular synthesis were examined. This
mutagenesis revealed that the short ORF is not essential for virus
replication. The AA dinucleotide at nt 2 and 3 is of critical
importance since point mutations and deletions that altered or removed
both of these nucleotides were lethal. None of the other mutations
within either the ss-leader or the 5'(+)SL [and accordingly within the 3'(
)SL], including deletions of up to 15 nt from the 5'(+)SL and
three different multiple-point mutations that lead to destabilization of the 5'(+)SL, were lethal. Some of the mutations within both ss-leader and the 5'(+)SL resulted in viruses that grew to lower titers
than the wild-type virus and formed opaque and/or small plaques; in
general mutations within the stem had a more profound effect
on viral phenotype than did mutations in either the ss-leader or upper
loop. Mutations in the 5'(+)SL, but not in the ss-leader, resulted in a
significant reduction in NSP synthesis, indicating that this structure
is important for efficient translation of the NSP ORF. In contrast,
viral plus-strand RNA synthesis was unaffected by the 5'(+)SL
mutations as well as the ss-leader mutations, which argues against
the proposed function of the 3'(
)SL as a promoter for initiation of
the genomic plus-strand RNA.
 |
INTRODUCTION |
Rubella virus (RUB) is the sole
member of the Rubivirus genus of the Togaviridae
family of animal viruses. This family also includes the
Alphavirus genus, whose type species is Sindbis virus (SIN).
In many regards, RUB is a typical representative of the togaviruses,
although important differences between RUB and the alphaviruses have
been discovered (reviewed in reference 7; the
molecular biology of alphaviruses is reviewed in reference 31). As with the alphaviruses, the RUB virion
contains an icosahedral nucleocapsid consisting of the single-stranded,
plus-polarity genomic RNA of approximately 10,000 nucleotides (nt) and
multiple copies of a single capsid protein C. The genomic RNA is capped and polyadenylated. The nucleocapsid is surrounded by a lipid envelope
containing two viral glycoproteins, E1 and E2. In the cytoplasm of
infected cells, the genomic RNA serves as an mRNA for translation of a
240-kDa polyprotein precursor that is posttranslationally cleaved by a
viral papain-like cysteine protease into P150 and P90, two
nonstructural proteins (NSPs) thought to function in virus RNA
replication (1, 5, 15). The NSPs are encoded by an open
reading frame (ORF) that covers the 5' terminal two-thirds of the
genome. It is in the processing of the NSP precursor that RUB
differs most from alphaviruses. The processing of the alphavirus precursor involves a sophisticated cascade of temporally regulated cleavages resulting in production of four NSPs as well as a number of
specific products of incomplete proteolysis. This process is believed
to orchestrate the course of virus RNA synthesis in which the different
polypeptides perform different specific functions (reviewed in
reference 31). In contrast, the single
cis cleavage mediated by the RUB NS protease would not allow
such an elaborate regulation.
The RUB genomic RNA next functions as the template for the synthesis of
a complementary genome-length, minus-polarity RNA which serves in turn
as the template for production of new genomic plus strands as well as a
subgenomic RNA. The subgenomic RNA contains sequences from the
3'-terminal one-third of the genome and is the mRNA for translation of
the structural proteins (SPs; C, E2, and E1) encoded by the SP ORF. The
individual SPs are generated by cotranslational cleavage of the
polyprotein precursor by cellular signalase. Synthesis of the
subgenomic RNA is initiated on the minus-strand template at a site
located between the two ORFs.
One of the most intriguing similarities between alphaviruses and RUB is
the conservation of three regions of homologous nucleotide sequence
and/or structure which are thought to be regulatory signals for viral
replication (3). One of these is a stem-and-loop structure at the 5' end of the genomic RNA [5'(+)SL]. The RUB 5'(+)SL
can stimulate translation of reporter genes both in vitro and
in vivo and was shown to bind a number of cellular proteins, one of
which is the La autoantigen (18, 24, 25). The functional significance of the cell protein binding is unknown.
In togaviruses, the complementary equivalent of the 5'(+)SL present
at the 3' end of viral minus-strand RNA [3'(
)SL] is thought to
serve as a promoter for initiation of genomic plus-strand RNA by the
viral replicase (31). The 3'(
)SL of both SIN and RUB have
been shown to bind cellular proteins (18, 20, 21); in the
case of SIN, one of these was identified as mosquito analog of the La
autoantigen (22). In SIN, the 5'(+)SL and 3'(
)SL occur at
the exact ends of the plus- and minus-strand RNAs. Site-directed mutagenesis of these structures conducted with an infectious clone of
SIN revealed that only deletions at the immediate end of the genomic
RNA (nt 5 or nt 2 to 4), which are located at the bottom of the stem,
were lethal (19). Deletions downstream from this site of 1 to 15 nt resulted in viable viruses, some of which grew less well than
the parental virus. Although the effect of these mutations on the viral
macromolecular synthesis was not examined, these observations are
currently considered as evidence of the importance of the 3'(
)SL for
initiation of genomic RNA synthesis. In terms of this model, RUB is a
convenient counterpart of SIN in that the 5'(+)SL is located 14 nt
downstream from the exact 5' end. Therefore, it should be possible to
perform similar mutagenic analysis of RUB to distinguish whether the
exact 5' nucleotides, the stem-and-loop structure, or both are crucial
for virus viability.
Another intriguing feature at the 5' end of the RUB genome is the
presence of a short ORF between nt 3 and 54 that could encode a
17-amino-acid peptide. This ORF overlaps the start of the NSP ORF at nt
41 in an alternate translational frame and thus could also potentially
downregulate translation of the NSP ORF. In this study, we determined
the 5'-terminal sequences of additional strains of RUB to ascertain
that both the secondary structure and the short ORF were conserved.
Then we used Robo302, an infectious clone of RUB (27), to
mutagenize the genomic 5' sequences to study the potential functional
significance of these features.
 |
MATERIALS AND METHODS |
Cells and viruses.
Vero cells obtained from the American
Type Culture Collection were maintained in Dulbecco's
modified Eagle medium (Gibco/BRL) containing 5% fetal bovine serum and
gentamicin (10 µg/ml) at 35°C under 5% CO2.
Propagation and titration of RUB by plaque assay was done as previously
described (5, 9, 34).
Construction of mutants.
Standard recombinant DNA techniques
(13) were used in these protocols, with minor modifications.
Restriction enzymes and T4 DNA ligase were obtained from New England
BioLabs or Boehringer Mannheim Biochemicals. Sequencing of DNA was done
by using dideoxy-chain termination sequencing kits from United States
Biochemicals (Cleveland, Ohio).
Mutations were created by PCR using pairs of primers containing the
desired mutations, ExTaq polymerase, which has a 3'-5' exonuclease proofreading activity (PanVera Corp., Madison, Wis.), and
EcoRI-linearized Robo302 plasmid as a template under
conditions optimized for amplification of the high G+C content RUB
sequences (27) with the exception that shorter
polymerization times (30 s to 1 min) were used in the PCR cycles. To
introduce mutations S3, S5, S10, D5, DSL2,
DSL4, DSL5, and ISL1 (see Fig. 3)
into Robo302, a HindIII-NcoI [39]
(numbers in brackets indicate positions)-restricted PCR fragment
containing the SP6 promoter and 5' end of the RUB genome through the
NcoI site at nt 39 containing the desired mutation was
ligated overnight with roughly equimolar amounts of
NcoI[39]-PinAI[816] and
PinAI[816]-HindIII restriction fragments
from Robo302 (the first fragment extends from the NcoI site
at nt 39 through the PinAI site at nt 816 of the genome,
while the second fragment contains the remainder of the RUB genome and
pCL1921 vector). Mutations DSL3, SSL2,
SSL3, and SSL4 were introduced by the same protocol, except that the HindIII-NcoI[39]
mutation-containing fragment was produced by annealing two partially
overlapping complementary oligonucleotides, filling in the
single-stranded regions with Klenow enzyme, and restricting with
HindIII and NcoI. To create mutations S1, S2,
S4, S6, S7, S8, S9, D1, D2, D3, D4, D6, D7, D8, D9, D10, D11,
SSL1, and DSL1, a
HindIII-PinAI[816]-restricted PCR fragment
(containing the SP6 RNA polymerase promoter and 5' end of
the RUB genome through the PinAI site at nt 816) containing the desired mutation was ligated with the
PinAI[816]-HindIII restriction fragment of
Robo302.
With many of the mutants (Fig. 3), following ligation the restriction
mixture was digested with EcoRI to linearize ligation products for runoff transcription, extracted with phenol-chloroform, and used directly in an in vitro transcription reaction. Alternatively, the ligation reaction was used to transform competent Escherichia coli MC1061 cells, and plasmids from several colonies were
isolated and sequenced to confirm the presence of the desired mutation. Two to three clones of each of the mutants were linearized with EcoRI prior to in vitro transcription and transfection.
In vitro transcription, transfection of cells, and confirmation
of mutations.
In vitro transcriptions using SP6 RNA polymerase in
the presence of m7G(5')ppp(5')G cap analog and
Lipofectin-mediated transfections of Vero cells with the resulting
transcripts were done as described elsewhere (27, 29).
Successful transcription was confirmed by agarose gel electrophoresis
of an aliquot of the transcription reaction in the presence of ethidium
bromide. The efficiency of in vitro transcription of the mutant
templates was comparable to that of Robo302, with the exception of the
S3 mutant, which produced approximately 10 times fewer transcripts.
Generally, duplicate plates of cells were transfected with each
transcription reaction; one plate was overlaid with agar, and the cells
in the other plate were maintained in growth medium. Five to six days later, characteristic plaques (if present) were picked, and virus was
eluted and amplified once in Vero cells to produce a stock for
sequencing to confirm the mutation and for subsequent analysis of the
mutant phenotype. If no plaques were observed, the growth medium from
the duplicate transfected culture was harvested and used as the mutant
virus stock. Sequencing to determine the genomic 5' ends of different
strains of RUB and to confirm the presence of mutations in the majority
of mutants was done as described previously (27). Briefly, a
120-nt primer extension product (PEP) complementary to the 5' end was
synthesized on virion RNA template, poly(A) tailed with terminal
deoxynucleotidyltransferase, and PCR amplified. The resulting PCR
product was cloned into pGEM1 or pGEM2 plasmid vector. To confirm the
DSL3, SSL2, SSL3, and SSL4 mutations, the protocol was modified such that
oligonucleotide 73 (5'-CAAGGATCCAGAACCTCATCTAGGAG;
the BamHI site used for cloning into pGEM1 vector is
underlined) was used in the PCR amplification step. This
oligonucleotide, complementary to nt 50 to 66, is closer to the 5' end
than oligonucleotides 36 and 292, used previously, and its use was
found to increase the specificity of PCR amplification of the
poly(A)-tailed PEP. To confirm the DSL2, DSL4,
DSL5, SSL1, ISL1, and
DSL1 mutations, the 5' PEP was not poly(A) tailed and was
instead directly PCR amplified by using oligonucleotide 74, containing
nt 1 to 18 of the genome (the first five of these mutations were
downstream from nt 18 and thus A tailing was not necessary; this method
was also useful for DSL1 due to the 3'-5' exonuclease activity of Deep Vent polymerase used). For each mutation, several plasmid clones containing the complete 5' terminus were identified and
sequenced.
Analysis of virus macromolecular synthesis.
RUB-specific RNA
and protein production was examined in cultures infected
simultaneously. Vero cells grown in 35- and 60-mm-diameter plates
(Corning Glass Works, Corning, N.Y.) and eight-chamber slides (Nunc,
Naperville, Ill.) (for immunofluorescence assay [IFA]) were infected
with Robo302 or mutant viruses at a multiplicity of infection (MOI) of
0.5 PFU/cell. At indicated times postinfection, total intracellular RNA
was extracted from the infected monolayers in the 35-mm-diameter plates
with TRI reagent (Molecular Research Center, Cincinnati, Ohio)
according to the manufacturer's protocol, redissolved in 40 µl of
H2O, and stored at
70°C. Aliquots of 4 µl were used
for Northern blotting, done as described previously (2).
[32P]dCTP nick-translated Robo102 plasmid (34)
was used as a probe for total RUB-specific RNA, and
[32P]-UTP-labeled RNA transcripts synthesized from
template plasmid pRUB-SP-ORF, which contains the 3'-terminal 3,292 nt
of the RUB genome (14), were used as strand-specific probes.
pRUB-SP-ORF was linearized with HindIII and transcribed
with T7 RNA polymerase or linearized with EcoRI and
transcribed with SP6 RNA polymerase to synthesize the minus- or
plus-strand specific probe, respectively.
Infected Vero cells grown in 60-mm-diameter plates were radiolabeled
for 1.5 h with [35S]methionine (1,000 Ci/mmol;
Amersham) and lysed in 1 ml of radioimmunoprecipitation buffer
(26) supplemented with 74 µM antipain dihydrochloride protease inhibitor (Boehringer Mannheim). Aliquots (200 µl) of these
lysates were mixed with 2 µl of a mixture of monoclonal antibodies
E1-20, E2-1, C2, and C8 (35) to immunoprecipitate the SPs.
Aliquots (800 µl) of the lysates were mixed with 7 µl of a mixture
of rabbit polyclonal antisera GU1 and GU8 (5) to
immunoprecipitate the NSPs. Immune complexes were recovered by using
protein A-Sepharose beads (Pharmacia), boiled for 2 min in sodium
dodecyl sulfate-containing sample loading buffer, and resolved by
electrophoresis on a sodium dodecyl sulfate-10% polyacrylamide gel.
Following autoradiography, the amount of radioactivity present in each
protein or RNA band was quantitated with a Fujix BAS1000 Bio Imaging
Analyzer (Fuji Photo Film, Tokyo, Japan), using software provided by
the manufacturer. The cells in the eight-chamber slides were fixed and
analyzed by IFA using monoclonal antibody E1-20 as described previously
(26) to determine the percentage of infected cells.
Computer analyses.
Optimal and suboptimal RNA secondary
structures were determined by using the FoldRNA and Mfold programs; the
output files of these programs were plotted by using the Squiggles
program (Genetics Computer Group, Madison, Wis.).
 |
RESULTS |
5'-terminal structure of the RUB genomic RNA.
The
5'-terminal stem-and-loop structure [5'(+)SL] shown in Fig.
1A was initially predicted by computer
(3). Its existence in the RUB genomic RNA is supported by
the finding that primer extension reactions near the 5' end of the
genomic RNA result in two strong-stop cDNA bands corresponding to the
last residue of the 5'(+)SL (nt 65) and the 5' end of the genome
(3). The 5'(+)SL follows a 14-nt single-stranded leader
(ss-leader). We call the vertical part of the stem-and-loop formed by
pairing of nt 15 to 29 and nt 51 to 65 the stem; the region consisting of nt 30 to 50 is called the upper loop. The predicted secondary structure of the genomic 5' end of SIN is shown for comparison in Fig.
1B. Also shown in Fig. 1A is the second element of interest in
this study, the short ORF located between nt 3 and 54, which overlaps
the start of the NSP ORF at nt 41 in an alternate frame.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Structures of the ends of the RNAs of RUB and SIN. The
5' terminus of the RUB genomic RNA (A) contains a 14-nt ss-leader
followed by a stem-and-loop structure [5'(+)SL] composed of nt 15 to
65. The 5'(+)SL of the genomic RNA of SIN (B) is located at the exact
5' end (nt 1 to 44). Start and stop codons for the short ORF of RUB are
underlined, and the initiation codons for the NSP ORF of both RUB and
SIN are shaded. A potential pseudoknot formed by the RUB 5' terminus is
also shown (this pseudoknot was not taken onto consideration to
determine the given G value). The predicted complementary
structure, 3'( )SL, located at the 3' end of the RUB minus-strand RNA,
is shown in panel C (numbering of nucleotides is from the 3' end).
|
|
The corresponding 3'(
)SL structure, complementary to the 5'(+)SL, is
shown in Fig. 1C. This structure is not an exact reflection of the
5'(+)SL and is less stable than the 5'(+)SL (
G =
15.2 kcal/mol versus
G =
20.7 kcal/mol). Also,
unlike the 5'(+)SL, which is preserved when longer stretches of the RUB
genome are folded, the 3'(
)SL disappeared when longer 3'
segments of minus-strand RNA were folded (for instance, 150-, 200-, 400-, and 1,000-nt segments) due to alternate pairing with
downstream sequences (data not shown).
Comparison of the 5' ends of six RUB strains.
Previously, the
sequence of the exact 5' terminus of the RUB genome had been determined
only for the w-Therien (wild-type [wt]) and RA27/3 (vaccine) strains
(28, 34). We determined the 5' sequences of four additional
strains: f-Therien, a laboratory derivative of w-Therien selected for
clear-plaque morphology (30); HPV-77, an independent vaccine
strain (7); Hasnas, a wt strain isolated in the United
States in 1990; and Machado, a wt strain isolated in Great Britain in
1992 (8). An alignment of these sequences is shown in Fig.
2. While the HPV-77 sequence is identical to that of w-Therien, the other strains differed by up to 3 nt within
the 5'-terminal 100 nt. Interestingly, the Hasnas genome starts with an
additional A residue. The Hasnas and Machado strains contain two of the
three differences found between RA27/3 (G7, U34, and G48) and w-Therien. The short ORF is
preserved in all of these strains. However, the nucleotide differences
within the short ORF would all result in amino acid substitutions in
the predicted peptide (N16
S in f-Therien;
E2
G, P11
L, and N16
D in
RA27/3; and E2
G and P11
L in Hasnas and
Machado).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 2.
Sequence alignment of the genomic 5' ends of different
strains of RUB. Abbreviations: w-Th, w-Therien; f-Th, f-Therien; RA,
RA27/3; Has, Hasnas; Mach, Machado. Start and stop codons for the short
ORF are boxed, and the initiation site of the NSP ORF is indicated by
the arrow.
|
|
The predicted effects of the strain differences on the 5'(+)SL and
3'(
)SL were analyzed, with the result that the length of the
ss-leader and the appearance of the stem of both structures (Fig. 1A
and C) are invariant in all strains. The upper loop part of the 5'(+)SL
(nt 30 to 50) and the corresponding part of the 3'(
)SL vary: they
have fewer paired bases in RA27/3, Hasnas, and Machado than in
w-Therien, f-Therien, and HPV-77 (data not shown). This relaxation in
the upper loop in some of the strains results in a reduction in the
estimated
G values of both the 5'(+)SL (
18.6 kcal/mol
for RA27/3 and
18.5 kcal/mol for Hasnas and Machado versus
20.7
kcal/mol for w-Therien, f-Therien, and HPV-77) and 3'(
)SL structures
(
13.7 kcal/mol for RA27/3 and
13.2 kcal/mol for Hasnas and Machado
versus
15.2 kcal/mol for w-Therien, f-Therien, and HPV-77).
Mutagenesis of the ss-leader sequence.
A number of deletions
of 1 to 6 nt (D1 to D11) and point mutations (S1 to S10) were
introduced into the ss-leader of Robo302 (Fig.
3). Surprisingly, the most profound
effects were produced by mutations that altered both A residues at nt 2 and 3. Deletions that led to removal of both A residues (D3, D4, D5,
and D6), as well as substitution of the AA with CC (S1), were lethal.
With the lethal mutants, no plaques were detected following
transfection of Vero cells. Additionally, no virion RNA of mutants D3
and D4 was detected in the media by reverse transcription-PCR, and no intracellular RUB-specific RNA of mutants S1 and D6 was detected by
Northern hybridization in Vero cells in which the media from the
initially transfected cells had been passaged (data not shown). The
other mutants were viable, and most grew to titers comparable to that
of Robo302 (Table 1). Mutations which
produced low titers following initial amplifications of plaques were
reassayed by using the amplified stock to infect Vero cells, with
harvest 2.5 days postinfection. Mutant D8 (nt 6 to 8 deleted) was found
to produce titers 10-fold lower than those of Robo302. Roughly half of
the mutants produced plaques with altered morphologies. With two
exceptions (D8 and D10, in which nt 6 to 8 and nt 9 to 11, respectively, were deleted), all of these had mutations within the
first 6 nt. Deletions within this region invariably gave rise to virus
with altered plaque morphology, whereas many of the base substitutions
produced virus with wt plaques.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
Mutations introduced into the 5' terminus of Robo302.
The wt (Robo302) sequence is boxed. Mutations in the ss-leader are
shown above the wt sequence, and mutations in the 5'(+)SL are shown
below the wt sequence. Mutations that were lethal are shaded, while
viable mutations are indicated by + in the "Viability" column.
Deviations from the wt plaque morphology exhibited by some of the
mutants are indicated in the "Plaque phenotype" column (Robo302
forms large, clear plaques). In the "Method" column, the procedure
of generation of each of the mutants is indicated: in E (express
method), the ligation mixture was used directly for in vitro
transcription followed by transfection of Vero cells, while in P
(plasmid method), plasmids containing the mutation were generated prior
to transcription and transfection. With both methods, mutations were
verified by 5' sequencing of mutant virion RNAs. The mutants marked by
asterisks were found to contain second site mutations (see Table 1 for
sequences).
|
|
The presence of the mutations in the generated virus samples was tested
by 5'-terminal sequencing of virion RNA (Table 1). While most of the
mutations were confirmed, viruses recovered from two mutations intended
to substitute the first residue of the AA dinucleotide at nt 2 and 3 were found to contain altered sequence: S2 virus RNA started with
5'-G0CAUGG instead of the intended
5'-G0CCAUGG, indicating that one of the two C
residues had been removed (G0 designates the additional
residue encoded in the in vitro RNA transcripts by the last nucleotide
of the SP6 promoter); and S3 virus RNA started with 5'-GAUGG
instead of the expected 5'-G0CGAUGG,
indicating that either G0C1 or
C1G2 were deleted. Additionally, mutant D9
virus was expected to start with
5'-G0C1AAUG5A12UC
(nt 6 to 11 are deleted). Instead, three of the four sequenced 5'
clones started with
5'-C1AAUG5A12UC1AAUG5A12UC, indicating that a duplication of the first 7 nt had occurred; the
fourth clone started with the expected sequence lacking G0. Presumably, these alterations in expected sequence were due to in vivo
mutations that occurred during virus replication following transfection. To eliminate the possibility that the alterations were
introduced by SP6 RNA polymerase during in vitro transcription, the
corresponding in vitro RNA transcripts were sequenced, with the result
that all transcripts were found to start with the expected sequence.
Additionally, the relative infectivity of S2 and S3 transcripts was
roughly 10 to 20 times lower than the infectivity of Robo302
transcripts, while all of the other mutant transcripts [including
mutations in the 5'(+)SL] had infectivities comparable to that
of Robo302. This finding also suggests that the initial S2 and S3
transcripts mutated following transfection. The D9 genotype appears to
be unstable, and the D9 virus used in this study is represented by a
mixture of the two variants.
In Robo302 virus harvested after one passage following transfection,
roughly 60% of the 5'-terminal clones contain the additional G0 residue, which disappears after five passages
(27). As shown in Table 1, different proportions of the
5'-terminal clones from some of the mutants also contain the
G0. Whether the G0 was maintained and
contributed to viability of some of the mutants (S2, S3, S4, etc.) is
unknown and remains to be investigated further.
Mutagenesis of the AUG initiation codon for the short ORF (nt 3 to 5)
to CUG, ACG, and AUA (mutants S6, S7, and S8, respectively) or
replacement of the third (G9CU) codon within the ORF to UAA termination codon (S10) yielded viable viruses with wt plaque morphology. These mutants grew to titers similar to Robo302 titers (Table 1). Thus, the short ORF is not required for replication. A
potential pseudoknot interaction can be configured between nt 2 to 6 and nt 33 to 37 (7) (Fig. 1A). Several of the mutations which would alter the stability of this pseudoknot gave rise to virus
with wt plaque morphology, while others yielded virus with altered
plaque morphology. One of these, S4 (A3
G substitution), led to opaque plaques. However, the S5 mutant was constructed to change
the complementary U36 residue in the pseudoknot to C. S5
virus formed opaque plaques indistinguishable from those formed by S4,
and thus the opaque-plaque phenotype is independent of the putative
pseudoknot.
Mutagenesis of the 5'(+)SL.
Five deletion mutations which were
intended to make gross changes in the structure were introduced into
the left side of the 5'(+)SL (Fig. 3): nt 15 to 21 at the bottom of the
stem (DSL1), nt 25 to 29 at the top of the stem
(DSL2), nt 15 to 29 (the entire left side of the stem;
DSL3), nt 30 to 35 in the lower part of the upper loop
region (DSL4), and nt 36 to 40 in the bulge of the upper
loop region preceding the A41UG initiation codon for the
NSP ORF (DSL5). No mutations were introduced downstream
from the AUG initiation codon for the NSP ORF (nt 41 to 43) situated at
the top of the 5'(+)SL, because the choice of mutations in this region
would have been restricted to a few 1-nt silent substitutions to
prevent alteration of the NSP amino acid sequence. Also, a 3-nt
substitution (G22CU
AUC) was made to sew up the bulge at the middle of the stem (SSL1), and a 4-nt (GUUU) insertion
was introduced between nt 29 and 30 to straighten and sew up the upper part of the 5'(+)SL (ISL1). The computer-predicted effects
of the mutations on the 5'(+)SL are shown in Fig.
4A. As expected, the mutations that
eliminated bulges are stronger than the wt structure (e.g.,
30
kcal/mol for ISL1 versus
20.7 kcal/mol in Robo302).
Interestingly, the mutants that deleted regions of the 5'(+)SL formed
alternate stem-and-loop structures utilizing nucleotides from the
ss-leader. However, these structures were weaker as well as unstable:
the 5'-terminal sequences were paired with different downstream regions
when longer 5'-terminal segments were folded (data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Predicted 5'-terminal structures of RNAs containing
mutations within the 5'(+)SL. (A) Effects of the five deletions
(DSL1 to 5), the mutation that sews up the bulge in the
stem (SSL1), and the 4-nt insertion in the upper loop
(ISL1) are shown. ISL1d virus is a clear-plaque
derivative selected during passage of ISL1 mutant in Vero
cells. (B) Effects of the three multiple-point mutations are shown. In
both panels, the localization of deletions is indicated by arrowhead
and inserted or substituted nucleotides are shaded. The NSP ORF
initiation codon is boxed.
|
|
All of these mutants were viable, and the presence of the intended
mutations was confirmed in each case. With exception of the
DSL4 mutant, which produced wt plaques, these mutants had altered plaque morphologies. Mutants DSL1 and
DSL2 formed plaques that were barely detectable.
DSL3 did not form plaques; however, a slight RUB-like
deterioration of cell monolayers was observed when cells were infected
with undiluted stocks of this virus. RUB-specific RNA was detected in
DSL3-infected cells by Northern hybridization (the amount
of the DSL3 RNA was 80 times lower than in Robo302-infected
cells) and thus this virus was viable, although no SPs or NSPs
were detectable in DSL3-infected cells by
radioimmunoprecipitation (data not shown). After mutant
ISL1, which forms opaque plaques, was amplified in Vero
cells, a small fraction of clear plaques was observed. The virus
from one of these plaques, subsequently called ISL1d, was
purified and its 5' end was sequenced. Surprisingly, it still contained
the entire insertion; however, one of the authentic nucleotides located
downstream from the insertion (U31) was deleted. This
deletion led to a slight relaxation in the upper part of the mutant
5'(+)SL (Fig. 4A). These mutants replicated less well than Robo302; the
titer range was from 2- to 20-fold lower when plaque isolates were
initially amplified but only 2- to 4-fold when these amplified stocks
were used in an experiment with a controlled MOI (Table 1).
As an alternative approach to alter the stem-and-loop structure, we
also made three different multiple-point mutations, SSL2, SSL3, and SSL4 (Fig. 3), that caused a profound
destabilizing effect in both the 5'(+)SL (Fig. 4B) and the
complementary 3'(
)SL as predicted by computer (data not shown)
without changing the overall length of the 5' untranslated region. All
three of these mutants were viable, and all three produced opaque
plaques. Two of these viruses, SSL2 and SSL4,
grew to titers comparable to that of Robo302, while SSL3
produced somewhat lower titers (Table 1). SSL3 also
produced smaller plaques that did the other two mutants.
Effects of selected mutations on the virus macromolecular
synthesis.
Monolayers of Vero cells were infected at an MOI of 0.5 PFU/cell with the following mutants: S2, S3, D7, D8, and D9, which contain mutations in the ss-leader (Fig. 3); and ISL1,
ISL1d, DSL1, DSL2,
SSL2, SSL3, and SSL4, which contain
mutations in the 5'(+)SL. Virus RNA and protein synthesis were analyzed
at both 48 and 72 h postinfection, with similar results at both
time points; analysis at 72 h postinfection is presented here.
Production of the plus-strand genomic and subgenomic RNAs is shown in
Fig. 5A. As can be seen, with none of the
mutants was synthesis of these RNAs significantly altered in comparison
with Robo302. The amount of RNA produced was roughly correlated with the percentage of cells infected at the time of analysis as determined by IFA, which varied from 40 to 50% for Robo302, S3, D7, D8,
DSL1, SSL2, and SSL4 to 60 to 70%
for S2, D9, SSL3, ISL1, ISL1d, and DSL2. The viruses which made the most RNA had the highest
infected cell percentage (e.g., D9 and S2). The genomic RNA/subgenomic RNA ratios among these viruses were also comparable, varying in the
range of ±30% from the ratio for Robo302. Structural protein synthesis is shown in Fig. 5B. As with RNA synthesis, SP synthesis did
not vary markedly among these viruses, and the amount of radioactivity in the SP bands was proportional to the intensity of the subgenomic RNA
bands.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of selected mutations on virus macromolecular
synthesis. Vero cells were infected with viruses indicated above each
lane at an MOI of 0.5 PFU/cell. At 72 h postinfection, total
intracellular RNAs were extracted and plus-strand RNAs were assayed by
Northern hybridization (A) or the cells were radiolabeled with
[35S]methionine and the SPs (B) and NSPs (C) were
immunoprecipitated and resolved by polyacrylamide gel electrophoresis.
In panel A, G signifies position of the genomic RNA band and SG
signifies the subgenomic RNA band. In panels B and C, positions of the
RUB-specific proteins and molecular weight markers (in kilodaltons) are
indicated on the left and right, respectively.
|
|
The most marked difference between the mutants was in NSP production,
as shown in Fig. 5C. Specifically, NSP synthesis was lower in the
5'(+)SL mutants than in Robo302 or the ss-leader mutants. NSP synthesis
normalized to SP synthesis is shown in Fig.
6. Particularly dramatic was the decrease
in NSP synthesis observed in mutants DSL1,
DSL2, and SSL4, whose NSP/SP ratios were
approximately four times lower than that of Robo302.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 6.
Relative rates of the NSP synthesis in cells infected
with the selected mutants. Amounts of radioactivities in the SP and NSP
bands in Fig. 5B and C were quantitated with a phosphorimager. Total
radioactivities in the NSP bands normalized to the radioactivity in the
SP bands for each virus are given (SP synthesis was found to be roughly
equivalent in all mutants).
|
|
 |
DISCUSSION |
In this study, we report the first use of the RUB infectious clone
for major genetic manipulation. Extensive mutagenesis was done on the
5' genomic sequences, and this mutagenesis was tolerated by the virus
in that the majority of the mutants were viable. Thus, the infectious
clone will be useful for site-directed mutagenesis studies.
As the first step in this study, we determined the genomic 5' sequences
of four additional strains of RUB (f-Therien, HPV, Hasnas, and Machado)
for comparative purposes since the 5' ends extending to the 5'-most
nucleotides of only two RUB strains, w-Therien and RA27/3, had been
sequenced previously (28, 34). The two major elements of the
5'-terminal secondary structure, the 14-nt ss-leader and the 5'(+)SL,
are present in all these strains. The stem part of the 5'(+)SL was
completely conserved in that no differences were found within the
regions (nt 15 to 29 and nt 51 to 65) that compose the stem. The six
strains differed at up to 3 nt localized in the ss-leader and the upper
loop part (nt 30 to 50) of the 5'(+)SL, and the differences in the
upper loop led to predicted structural differences. This finding is consistent with results of Johnstone et al. (10), who
sequenced nt 18 to 540 of seven different strains and found no
difference in the stem but variation in the upper loop that led to
variability in the predicted structure. The maintenance of the stem and
the variability of the upper loop correlated with the mutagenesis results in that mutations in the stem resulted in more dramatic effects
on the virus growth and plaque morphology compared to deletions in the
upper loop.
In addition to the secondary structure, an interesting feature at the
5' terminus addressed in this study is the short ORF located between nt
3 and 54 of the RUB genome that overlaps the NSP ORF in an alternate
translation frame. We found that this ORF was preserved in the six
independent strains; however, its coding sequence was not as highly
conserved as would be expected of a short peptide that plays a
significant function in the virus replication cycle since up to three
substitutions within the encoded 17 amino acid residues were found in
some strains. Subsequently, we made mutations that interfered with or
excluded translation of this ORF, and the resulting mutant viruses were
found to be viable and have wild-type growth and plaque morphology.
Therefore, this short ORF is not required for the virus replication.
Mutagenesis of the 5'(+)SL was initially approached by deleting
portions of the stem and upper loop and yielded the overall result that
none of these mutations, including a 15-nt deletion of the entire left
side of the conserved stem (mutant DSL3), were lethal,
although this latter mutant was severely crippled. The deletions in the
stem had a greater effect on virus titer and plaque morphology than did
the deletions in the upper loop. Computer-assisted refolding of these
deletions indicated that stem structures could still be formed,
sometimes with nucleotides in the ss-leader; however, these structures
were both weaker and less stable. The mutations that resulted in the
weakest stem structure had the greatest effect on plaque morphology. To
profoundly modify the appearance of the 5' secondary structure without
changing the length of the 5' untranslated region, we made three
multiple-point mutations (SSL2, SSL3, and
SSL4) which were predicted to completely alter the 5'(+)SL.
All three of these mutants exhibited altered plaque morphology, and two
grew to titers that approached Robo302 titers. The mutant that grew
roughly 10 times less well than Robo302 and had the severest alteration
in plaque morphology (SSL3) had the least stable 5'
structure. Therefore, there appears to be a requirement for a stem
structure with some degree of stability at the 5' end of the RUB genome
for efficient replication. Overall, these findings are in accordance
with the results of a similar study conducted on the 5' end of SIN in
which it was shown that various deletions within the 5'(+)SL of SIN of
up to 15 nt in length introduced downstream from nt 5 were not lethal
but had variable effects on virus replication (19). In the
SIN study, deletions within the first 5' nt of the 5'(+)SL were lethal
(except for deletion of nt 1, which was viable). However, as discussed below, we believe that this was due to the fact that these nucleotides are the first 5 nt of the SIN genome and not because they are part of
the 5'(+)SL.
At the molecular level, the only parameter that differed among
different mutants was production of NSPs, which was reduced by the
mutations in the 5'(+)SL but not in the ss-leader. Thus, the 5'(+)SL is
important for efficient initiation of translation of the NSP ORF. This
finding is consistent with previous observations of a stimulatory
effect of this structure on translation of reporter genes in vitro and
in vivo (18, 24, 25). The La autoantigen has been shown to
bind the 5'(+)SL, and some evidence indicates that La binding increases
the efficiency of translation of the NSP ORF (4). It will be
interesting to measure the effect of our 5'(+)SL mutations on La
binding. Especially profound suppression of NSP synthesis was observed
in mutants DSL1 and DSL2, which formed barely
detectable plaques, and no viral proteins were detectable in mutant
DSL3, which failed to form plaques. This observation is
consistent with our recent findings indicating that the level of NSP
synthesis can be an important determinant of RUB cytopathogenicity (27).
Computer folding demonstrated that the 3'(
)SL at the 3' end of the
minus-strand RNA of RUB is weaker than the 5'(+)SL and was destabilized
by the mutations introduced into the 5'(+)SL. Since these mutations did
not preclude viability and did not significantly affect plus-strand RNA
synthesis, we conclude that the 3'(
)SL is not a negative-strand
promoter necessary for initiation of genomic plus strands. As discussed
above, large alterations in the 5'(+)SL of the SIN infectious clone
were tolerated, although the effect of these mutations on plus-strand
RNA synthesis was not studied (19). The other published data
that argue against the idea of the 3'(
)SL being a promoter are the
findings that the 5' noncoding sequences in defective interfering RNAs
of both Semliki Forest virus (12, 23) and SIN (16, 17,
32, 33) are highly rearranged, with large portions of the 5'(+)SL
being deleted and/or replaced by heterologous sequences of both viral and cellular origin. Computer analysis failed to recognize any common
5'-terminal secondary structure among such defective interfering RNAs
of SIN (33). In this regard, minus-strand RNA is completely complexed in double-stranded replicative forms and replicative intermediates in togavirus-infected cells which are the templates for
plus-strand RNA synthesis (11). It is not known if these RNAs are unwound by themselves to any extent, and thus it is possible that formation of any secondary structure by the minus-strand RNA, such
as the 3'(
)SL, does not occur. In this case, initiation of
plus-strand RNA could occur by template switching by the replicase from
the plus-strand to the minus-strand template or by recognition of a
double-stranded RNA feature. However, if such unwinding indeed takes
place, then the possibility remains that a specific, more complex
tertiary structure of a larger 3' segment of the minus-strand RNA
serves as a promoter for the plus-strand RNA.
Perhaps the most intriguing finding in this study was that only a few
nucleotides at the extreme 5' end of the genome were essential for RUB
viability. Specifically, mutations that removed or altered the two A
residues at nt 2 and 3 simultaneously (but not mutations that altered
only one of these residues) were lethal. Mutations that changed the
first A residue resulted in viable viruses, which however contained
secondary mutations that moved an A residue within the first 3 nt of
the genome. This finding coincides with the SIN mutagenesis study in
which deletions in the first 5 nt were found to be lethal
(19). Since the crucial AA dinucleotide in the RUB genome is
located in the ss-leader, this indicates that in both RUB and SIN the
5'-most nucleotides are critical in virus replication, but not because
in SIN they belong to the bottom of the 5'(+)SL as was previously
suggested (19). It is possible that these residues
constitute a core element of a short signal at the 5' end of genomic
RNA (or 3' end of the minus-strand RNA) which is absolutely necessary
for RNA replication. However, the signal is not as simple as one or
more A's near the 5' end of the genome, since D5, which moved the
A7A8 dinucleotide to the exact 5' end, was
lethal. It should be noted that D8, which lacked
G6A7A8, gave rise to a small-plaque
phenotype virus, while D9, which lacked nt 6 to 11, gave rise to a
virus with a duplicated 5' end. Thus, nt 6 to 8 as well as some other
surrounding nucleotides may also play a role in this putative signal.
Alternatively, it has been shown that alphavirus genomic RNAs cyclize
through interactions of nucleotides near the 5' and 3' ends of the
molecule (6). Although the function of cyclization, as well
as whether or not the RUB genomic RNA cyclizes, is not known, the exact
5' nucleotides of the togavirus genomes could be involved in
cyclization. Further analysis is required to resolve these
possibilities.
 |
ACKNOWLEDGMENTS |
This study was supported by grant AI-21389 from NIH. Funds for
purchase of a phosphorimager were provided by the Georgia Research Alliance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biology, Georgia State University, 24 Peachtree Center Ave., Atlanta, GA 30303. Phone: (404) 651-3105. Fax: (404) 651-2509. E-mail: biotkf{at}panther.gsu.edu.
 |
REFERENCES |
| 1.
|
Chen, J.-P.,
J. H. Strauss,
E. G. Strauss, and T. K. Frey.
1996.
Characterization of the rubella virus nonstructural protease domain and its cleavage site.
J. Virol.
70:4707-4713[Abstract].
|
| 2.
|
Derdeyn, C. A., and T. K. Frey.
1995.
Characterization of defective-interfering RNAs of rubella virus generated during serial undiluted passage.
Virology
206:216-226[Medline].
|
| 3.
|
Dominguez, G.,
C. Y. Wang, and T. K. Frey.
1990.
Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during Togavirus evolution.
Virology
177:225-238[Medline].
|
| 4.
| Duncan, R. C., and H. L. Nakhasi.
Personal communication.
|
| 5.
|
Forng, R.-Y., and T. K. Frey.
1995.
Identification of the rubella virus nonstructural proteins.
Virology
206:843-853[Medline].
|
| 6.
|
Frey, T. K.,
D. L. Gard, and J. H. Strauss.
1979.
Biophysical studies on circle formation by Sindbis virus 49S RNA.
J. Mol. Biol.
132:1-18[Medline].
|
| 7.
|
Frey, T. K.
1994.
Molecular biology of rubella virus.
Adv. Virus Res.
44:69-160[Medline].
|
| 8.
|
Frey, T. K., and E. S. Abernathy.
1993.
Identification of strain-specific nucleotide sequences in the RA27/3 rubella virus vaccine.
J. Infect. Dis.
168:854-864[Medline].
|
| 9.
|
Hemphill, M. L.,
R.-Y. Forng,
E. S. Abernathy, and T. K. Frey.
1988.
Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells.
Virology
162:65-75[Medline].
|
| 10.
|
Johnstone, P.,
J. E. Whitby,
T. Bosma,
J. M. Best, and P. G. Sanders.
1996.
Sequence variation in the 5' termini of rubella virus genomes: changes affecting structure of the 5' proximal stem-loop.
Arch. Virol.
141:2471-2477[Medline].
|
| 11.
|
Kennedy, S. I. T.
1980.
Synthesis of alphavirus RNA, p. 351-369. In
R. W. Schlesinger (ed.), The togaviruses: biology, structure, replication.
Academic Press, New York, N.Y.
|
| 12.
|
Lentovaara, P.,
H. Soderlund,
S. Keranen,
R. F. Pettersson, and L. Kaariainen.
1982.
Extreme ends of the genome are conserved and rearranged in the defective interfering RNAs of Semliki Forest virus.
J. Mol. Biol.
156:731-748[Medline].
|
| 13.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1992.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 14.
|
Marr, L. D.,
A. Sanchez, and T. K. Frey.
1991.
Efficient in vitro translation of the rubella virus structural proteins in the presence of microsoms.
Virology
180:400-405[Medline].
|
| 15.
|
Marr, L. D.,
C.-Y. Wang, and T. K. Frey.
1994.
Expression of rubella virus nonstructural protein ORF and demonstration of proteolytic processing.
Virology
198:586-592[Medline].
|
| 16.
|
Monroe, S. S., and S. Schlesinger.
1983.
RNAs from two independently isolated defective interfering particles of Sindbis virus contain a cellular tRNA sequence at their 5' ends.
Proc. Natl. Acad. Sci. USA
80:3279-3283[Abstract/Free Full Text].
|
| 17.
|
Monroe, S. S., and S. Schlesinger.
1984.
Common and distinct regions of defective-interfering RNAs of Sindbis virus.
J. Virol.
49:865-872[Abstract/Free Full Text].
|
| 18.
|
Nakhasi, H. L.,
N. K. Singh,
G. P. Pogue, and X.-Q. Cao.
1994.
Identification and characterization of host factor interactions with cis-acting elements of rubella virus.
Arch. Virol.
9:255-267.
|
| 19.
|
Niesters, H. G. M., and J. H. Strauss.
1990.
Defined mutations in the 5' nontranslated sequence of Sindbis virus RNA.
J. Virol.
64:4162-4168[Abstract/Free Full Text].
|
| 20.
|
Pardigon, N., and J. H. Strauss.
1992.
Cellular proteins bind to the 3' end of Sindbis virus minus-strand RNA.
J. Virol.
66:1007-1015[Abstract/Free Full Text].
|
| 21.
|
Pardigon, N.,
E. Lenches, and J. H. Strauss.
1993.
Multiple binding sites for cellular proteins in the 3' end of Sindbis alphavirus minus-sense RNA.
J. Virol.
67:5003-5011[Abstract/Free Full Text].
|
| 22.
|
Pardigon, N., and J. H. Strauss.
1996.
Mosquito homolog of the La autoantigen binds to Sindbis virus RNA.
J. Virol.
70:1173-1181[Abstract].
|
| 23.
|
Pettersson, R. F.
1981.
5'-terminal nucleotide sequence of Semliki Forest virus 18S defective interfering RNA is heterogeneous and different from the genomic 42S RNA.
Proc. Natl. Acad. Sci. USA
78:115-119[Abstract/Free Full Text].
|
| 24.
|
Pogue, G. P.,
X.-Q. Cao,
N. K. Singh, and H. L. Nakhasi.
1993.
5' sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins.
J. Virol.
67:7106-7117[Abstract/Free Full Text].
|
| 25.
|
Pogue, G. P.,
J. Hofmann,
R. Duncan,
J. M. Best,
J. Etherington,
R. D. Sontheimer, and H. L. Nakhasi.
1996.
Autoantigens interact with cis-acting elements of rubella virus RNA.
J. Virol.
70:6269-6277[Abstract].
|
| 26.
|
Pugachev, K. V.,
P. W. Mason, and T. K. Frey.
1995.
Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants.
Virology
209:155-166[Medline].
|
| 27.
|
Pugachev, K. V.,
E. S. Abernathy, and T. K. Frey.
1997.
Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins.
J. Virol.
71:562-568[Abstract].
|
| 28.
|
Pugachev, K. V.,
E. S. Abernathy, and T. K. Frey.
1997.
Genomic sequence of the RA27/3 vaccine strain of rubella virus.
Arch. Virol.
142:1165-1180[Medline].
|
| 29.
|
Rice, C. M.,
A. Grakoui,
R. Galler, and T. J. Chambers.
1989.
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation.
New Biol.
1:285-296[Medline].
|
| 30.
| Salmi, A. Personal communication.
|
| 31.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 32.
|
Tsiang, M.,
S. S. Monroe, and S. Schlesinger.
1985.
Studies of defective interfering RNAs of Sindbis virus with and without tRNAAsp sequences at their 5' termini.
J. Virol.
54:38-44[Abstract/Free Full Text].
|
| 33.
|
Tsiang, M.,
B. G. Weiss, and S. Schlesinger.
1988.
Effects of 5'-terminal modifications on the biological activity of defective interfering RNAs of Sindbis virus.
J. Virol.
62:47-55[Abstract/Free Full Text].
|
| 34.
|
Wang, C. Y.,
G. Dominguez, and T. K. Frey.
1994.
Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts.
J. Virol.
68:3550-3557[Abstract/Free Full Text].
|
| 35.
|
Wolinsky, J. S.,
M. McCarthy,
O. Allen-Cannady,
W. T. Moore,
R. Jin,
S.-N. Cao,
A. Lovett, and D. Simmons.
1991.
Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
J. Virol.
65:3986-3994[Abstract/Free Full Text].
|
J Virol, January 1998, p. 641-650, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Claus, C., Tzeng, W.-P., Liebert, U. G., Frey, T. K.
(2007). Rubella virus-induced superinfection exclusion studied in cells with persisting replicons. J. Gen. Virol.
88: 2769-2773
[Abstract]
[Full Text]
-
Decca, M. B., Carpio, M. A., Bosc, C., Galiano, M. R., Job, D., Andrieux, A., Hallak, M. E.
(2007). Post-translational Arginylation of Calreticulin: A NEW ISOSPECIES OF CALRETICULIN COMPONENT OF STRESS GRANULES. J. Biol. Chem.
282: 8237-8245
[Abstract]
[Full Text]
-
Tzeng, W.-P., Matthews, J. D., Frey, T. K.
(2006). Analysis of rubella virus capsid protein-mediated enhancement of replicon replication and mutant rescue.. J. Virol.
80: 3966-3974
[Abstract]
[Full Text]
-
Choi, Y.-J., Yun, S.-I., Kang, S.-Y., Lee, Y.-M.
(2006). Identification of 5' and 3' cis-Acting Elements of the Porcine Reproductive and Respiratory Syndrome Virus: Acquisition of Novel 5' AU-Rich Sequences Restored Replication of a 5'-Proximal 7-Nucleotide Deletion Mutant. J. Virol.
80: 723-736
[Abstract]
[Full Text]
-
TORTORICI, M. A., SHAPIRO, B. A., PATTON, J. T.
(2006). A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments. RNA
12: 133-146
[Abstract]
[Full Text]
-
Timchenko, N. A., Wang, G.-L., Timchenko, L. T.
(2005). RNA CUG-binding Protein 1 Increases Translation of 20-kDa Isoform of CCAAT/Enhancer-binding Protein {beta} by Interacting with the {alpha} and {beta} Subunits of Eukaryotic Initiation Translation Factor 2. J. Biol. Chem.
280: 20549-20557
[Abstract]
[Full Text]
-
Gorchakov, R., Hardy, R., Rice, C. M., Frolov, I.
(2004). Selection of Functional 5' cis-Acting Elements Promoting Efficient Sindbis Virus Genome Replication. J. Virol.
78: 61-75
[Abstract]
[Full Text]
-
Timchenko, L. T., Iakova, P., Welm, A. L., Cai, Z.-J., Timchenko, N. A.
(2002). Calreticulin Interacts with C/EBP{alpha} and C/EBP{beta} mRNAs and Represses Translation of C/EBP Proteins. Mol. Cell. Biol.
22: 7242-7257
[Abstract]
[Full Text]
-
Lee, J.-Y., Bowden, D. S.
(2000). Rubella Virus Replication and Links to Teratogenicity. Clin. Microbiol. Rev.
13: 571-587
[Abstract]
[Full Text]
-
Lund, K. D., Chantler, J. K.
(2000). Mapping of Genetic Determinants of Rubella Virus Associated with Growth in Joint Tissue. J. Virol.
74: 796-804
[Abstract]
[Full Text]
-
Chen, M.-H., Frey, T. K.
(1999). Mutagenic Analysis of the 3' cis-Acting Elements of the Rubella Virus Genome. J. Virol.
73: 3386-3403
[Abstract]
[Full Text]